GWM
ANVS icon

Greenwich Wealth Management’s Annovis Bio ANVS Stock Holding History

Greenwich Wealth Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90K Buy
48,400
+1,400
+3% +$2.72K ﹤0.01% 292
2026
Q1 		$105K Buy
47,000
+4,600
+11% +$12.6K ﹤0.01% 298
2025
Q4 		$147K Sell
42,400
-5,000
-11% -$15K 0.01% 278
2025
Q3 		$98K Buy
47,400
+400
+0.9% +$1K ﹤0.01% 270
2025
Q2 		$102K Buy
47,000
+900
+2% +$1.78K 0.01% 243
2025
Q1 		$69K Buy
46,100
+14,149
+44% +$43.3K 0.01% 234
2024
Q4 		$161K Buy
31,951
+15,476
+94% +$112K 0.01% 244
2024
Q3 		$133K Buy
16,475
+1,400
+9% +$13.1K 0.01% 236
2024
Q2 		$87K Buy
15,075
+2,500
+20% +$20.3K 0.01% 234
2024
Q1 		$150K Buy
12,575
+2,300
+22% +$25.1K 0.01% 229
2023
Q4 		$192K Buy
+10,275
New +$91.1K 0.02% 218

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Greenwich Wealth Management's ANVS Position: Q2 2026 in Review

Greenwich Wealth Management increased its Annovis Bio (ANVS) stake by 3% in Q2 2026, buying an estimated $2.72K and bringing the position to 48,400 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #292.

Greenwich Wealth Management first reported a position in ANVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $192K in Q4 2023. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Greenwich Wealth Management held 48,400 shares of Annovis Bio worth $90K as of Q2 2026.
  • Greenwich Wealth Management bought 1,400 Annovis Bio shares in Q2 2026, an estimated $2.72K.
  • Annovis Bio made up ﹤0.01% of Greenwich Wealth Management's portfolio in Q2 2026, its #292 holding.
  • Greenwich Wealth Management first reported a position in Annovis Bio in Q4 2023 and has held it in 11 quarters since.
  • Greenwich Wealth Management's Annovis Bio position peaked at $192K in Q4 2023.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Greenwich Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.